Literature DB >> 21928101

Implantation of a Jarvik 2000 left ventricular assist device as a bridge to eligibility for refractory heart failure with renal dysfunction.

Satoshi Kainuma1, Taichi Sakaguchi, Shunsuke Saito, Shigeru Miyagawa, Yasushi Yoshikawa, Takashi Yamauchi, Yasushi Sakata, Atsushi Takahashi, Takuya Uehata, Toru Kuratani, Yoshiki Sawa.   

Abstract

A 55-year-old man, who previously underwent surgical ventricular restoration and mitral valve surgery, was referred to our department for management of refractory heart and multiple organ failure. At the time of admission to our hospital, he could not be registered as a candidate for heart transplantation because of severe renal failure with a serum creatinine level of 4.6 mg/dl. We considered that he was a marginal candidate for heart transplantation; thus, it was essential to understand the etiology of renal failure and estimate whether it was reversible. Cardiac catheterization revealed poor hemodynamic function with a systemic pressure of 107/60 mmHg, cardiac index of 2.5 l/min/m(2), and pulmonary artery pressure of 63/27 mmHg, despite intense medical treatment. Contrary to biochemical examination findings of blood, renal biopsy findings showed no significant glomerular abnormality. Furthermore, the severity of tubular atrophy and interstitial fibrosis in the cortex was mild. These pathological findings suggested that the renal dysfunction in this case was possibly attributable to a hemodynamic factor. His symptoms gradually deteriorated despite an increasing dose of inotropic support; thus, we planned implantation of a Jarvik 2000 axial-flow pump (Jarvik Heart Inc., New York, NY, USA) as a bridge to eligibility, and informed consent was obtained. Because of a tight adhesion on the anterior wall, we placed the device on the lateral wall of the left ventricle, making sure not to direct the pump at the septum. Postoperatively, the implantable left ventricular assist device provided relief from heart failure symptoms as well as recovery of renal function, with serum the creatinine level at 1.2 mg/dl, which allowed the patient to become an appropriate candidate for heart transplantation. At an 18-month follow-up examination, his status was uneventful, and he is now at home awaiting heart transplantation.

Entities:  

Mesh:

Year:  2011        PMID: 21928101     DOI: 10.1007/s10047-011-0602-8

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  12 in total

1.  Relationship between renal function and left ventricular assist device use.

Authors:  Javed Butler; Carrie Geisberg; Renee Howser; Peer M Portner; Joseph G Rogers; Mario C Deng; Richard N Pierson
Journal:  Ann Thorac Surg       Date:  2006-05       Impact factor: 4.330

Review 2.  Mechanical circulatory support for advanced heart failure: where does it stand in 2003?

Authors:  O H Frazier; Reynolds M Delgado
Journal:  Circulation       Date:  2003-12-23       Impact factor: 29.690

3.  Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: second annual report--2004.

Authors:  Mario C Deng; Leah B Edwards; Marshall I Hertz; Amanda W Rowe; Berkeley M Keck; Robert Kormos; David C Naftel; James K Kirklin
Journal:  J Heart Lung Transplant       Date:  2004-09       Impact factor: 10.247

4.  Cardiac replacement with a total artificial heart as a bridge to transplantation.

Authors:  Jack G Copeland; Richard G Smith; Francisco A Arabia; Paul E Nolan; Gulshan K Sethi; Pei H Tsau; Douglas McClellan; Marvin J Slepian
Journal:  N Engl J Med       Date:  2004-08-26       Impact factor: 91.245

5.  Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system.

Authors:  O H Frazier; Timothy J Myers; Igor D Gregoric; Tehreen Khan; Reynolds Delgado; Mihai Croitoru; Kathy Miller; Robert Jarvik; Stephen Westaby
Journal:  Circulation       Date:  2002-06-18       Impact factor: 29.690

6.  Midterm experience with the Jarvik 2000 axial flow left ventricular assist device.

Authors:  Saleem Haj-Yahia; Emma J Birks; Paula Rogers; Christopher Bowles; Mandy Hipkins; Robert George; Mohammed Amrani; Mario Petrou; John Pepper; Gilles Dreyfus; Asghar Khaghani
Journal:  J Thorac Cardiovasc Surg       Date:  2007-07       Impact factor: 5.209

7.  Renal function and outcome after continuous flow left ventricular assist device implantation.

Authors:  Sigrid E Sandner; Daniel Zimpfer; Philipp Zrunek; Angela Rajek; Heinrich Schima; Daniela Dunkler; Michael Grimm; Ernst Wolner; Georg M Wieselthaler
Journal:  Ann Thorac Surg       Date:  2009-04       Impact factor: 4.330

8.  Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

Authors:  G Maschio; D Alberti; G Janin; F Locatelli; J F Mann; M Motolese; C Ponticelli; E Ritz; P Zucchelli
Journal:  N Engl J Med       Date:  1996-04-11       Impact factor: 91.245

9.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

10.  Blood pressure and end-stage renal disease in men.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245

View more
  3 in total

Review 1.  Journal of Artificial Organs 2012: the year in review.

Authors:  Y Sawa; E Tatsumi; T Tsukiya; K Matsuda; K Fukunaga; A Kishida; T Masuzawa; G Matsumiya; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2013-02-28       Impact factor: 1.731

2.  Clinical results with Jarvik 2000 axial flow left ventricular assist device: Osaka University Experience.

Authors:  Daisuke Yoshioka; Goro Matsumiya; Koichi Toda; Taichi Sakaguchi; Yasushi Yoshikawa; Shunsuke Saito; Hikaru Matsuda; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2014-07-22       Impact factor: 1.731

Review 3.  Left ventricular assist devices: a kidney's perspective.

Authors:  T R Tromp; N de Jonge; J A Joles
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.